Ben Marafino to Antibodies, Monoclonal
This is a "connection" page, showing publications Ben Marafino has written about Antibodies, Monoclonal.
Connection Strength
0.235
-
Commercial development considerations for biotechnology-derived therapeutics. Cardiovasc Toxicol. 2003; 3(1):5-12.
Score: 0.213
-
Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals. Regul Toxicol Pharmacol. 2010 Nov; 58(2):243-51.
Score: 0.022